Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination

por Takheaw, Nuchjira, Liwsrisakun, Chalerm, Chaiwong, Warawut, Laopajon, Witida, Pata, Supansa, Inchai, Juthamas, Duangjit, Pilaiporn, Pothirat, Chaicharn, Bumroongkit, Chaiwat, Deesomchok, Athavudh, Theerakittikul, Theerakorn, Limsukon, Atikun, Tajarernmuang, Pattraporn, Niyatiwatchanchai, Nutchanok, Trongtrakul, Konlawij, Kasinrerk, Watchara
Publicado 2022

Highly sensitive aptasensor for the detection of SARS-CoV-2-RBD using aptamer-gated methylene blue@mesoporous silica film/laser engraved graphene electrode

por Amouzadeh Tabrizi, Mahmoud, Acedo, Pablo
Publicado 2022

Passive immunization with equine RBD-specific Fab protects K18-hACE2-mice against Alpha or Beta variants of SARS-CoV-2

por Barbier, Mariette, Lee, Katherine S., Vikharankar, Mayur S., Rajpathak, Shriram N., Kadam, Nandkumar, Wong, Ting Y., Russ, Brynnan P., Cyphert, Holly A., Miller, Olivia A., Rader, Nathaniel A., Cooper, Melissa, Kang, Jason, Sen-Kilic, Emel, Wong, Zeriel Y., Winters, Michael T., Bevere, Justin R., Martinez, Ivan, Devarumath, Rachayya, Shaligram, Umesh S., Damron, F. Heath
Publicado 2022

A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants

por Zhang, Jing, Han, Zi Bo, Liang, Yu, Zhang, Xue Feng, Jin, Yu Qin, Du, Li Fang, Shao, Shuai, Wang, Hui, Hou, Jun Wei, Xu, Ke, Lei, Wenwen, Lei, Ze Hua, Liu, Zhao Ming, Zhang, Jin, Hou, Ya Nan, Liu, Ning, Shen, Fu Jie, Wu, Jin Juan, Zheng, Xiang, Li, Xin Yu, Li, Xin, Huang, Wei Jin, Wu, Gui Zhen, Su, Ji Guo, Li, Qi Ming
Publicado 2022

Safety and effectiveness of RBD-specific polyclonal equine F(ab´)(2) fragments for the treatment of hospitalized patients with severe Covid-19 disease: A retrospective cohort study

por Farizano Salazar, Diego H., Achinelli, Fernando, Colonna, Mariana, Pérez, Lucía, Giménez, Analía A., Ojeda, Maria Alejandra, Miranda Puente, Susana N., Sánchez Negrette, Lía, Cañete, Florencia, Martelotte Ibarra, Ornela I., Sanguineti, Santiago, Spatz, Linus, Goldbaum, Fernando A., Massa, Carolina, Rivas, Marta, Pichel, Mariana, Hiriart, Yanina, Zylberman, Vanesa, Gallego, Sandra, Konigheim, Brenda, Fernández, Francisco, Deprati, Matías, Roubicek, Ian, Giunta, Diego H., Nannini, Esteban, Lopardo, Gustavo, Belloso, Waldo H.
Publicado 2022

Immunoglobulin yolk targeting spike 1, receptor binding domain of spike glycoprotein and nucleocapsid of SARS-CoV-2 blocking RBD-ACE2 binding interaction

por Eka Saputri, Meliana, Aisyah Rahmalia Effendi, Siti, Nadila, Rifa, Azzam Fajar, Syauqi, Damajanti Soejoedono, Retno, Handharyani, Ekowati, Nadia Poetri, Okti
Publicado 2022

Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers

por Zare, Hamed, Rezapour, Hadis, Fereidouni, Alireza, Nikpour, Saboura, Mahmoudzadeh, Sara, Royce, Simon G, Fereidouni, Mohammad
Publicado 2022

Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement

por Abu-Humaidan, Anas H. A., Ahmad, Fatima M., Awajan, Dima, Jarrar, Raba'a F., Alaridah, Nader
Publicado 2022

Effect of Double Mutation (L452R and E484Q) on the Binding Affinity of Monoclonal Antibodies (mAbs) against the RBD—A Target for Vaccine Development

por Gupta, Deepali, Kumar, Mukesh, Sharma, Priyanka, Mohan, Trishala, Prakash, Amresh, Kumari, Renu, Kaur, Punit
Publicado 2022

RBD-Based ELISA and Luminex Predict Anti-SARS-CoV-2 Surrogate-Neutralizing Activity in Two Longitudinal Cohorts of German and Spanish Health Care Workers

por Aguilar, Ruth, Li, Xue, Crowell, Claudia S., Burrell, Teresa, Vidal, Marta, Rubio, Rocio, Jiménez, Alfons, Hernández-Luis, Pablo, Hofmann, Dieter, Mijočević, Hrvoje, Jeske, Samuel, Christa, Catharina, D'Ippolito, Elvira, Lingor, Paul, Knolle, Percy A., Roggendorf, Hedwig, Priller, Alina, Yazici, Sarah, Carolis, Carlo, Mayor, Alfredo, Schreiner, Patrik, Poppert, Holger, Beyer, Henriette, Schambeck, Sophia E., Izquierdo, Luis, Tortajada, Marta, Angulo, Ana, Soutschek, Erwin, Engel, Pablo, Garcia-Basteiro, Alberto, Busch, Dirk H., Moncunill, Gemma, Protzer, Ulrike, Dobaño, Carlota, Gerhard, Markus
Publicado 2023

A randomized phase I/II safety and immunogenicity study of the Montanide-adjuvanted SARS-CoV-2 spike protein-RBD-Fc vaccine, AKS-452

por Feitsma, Eline A., Janssen, Yester F., Boersma, Hendrikus H., van Sleen, Yannick, van Baarle, Debbie, Alleva, David G., Lancaster, Thomas M., Sathiyaseelan, Thillainaygam, Murikipudi, Sylaja, Delpero, Andrea R., Scully, Melanie M., Ragupathy, Ramya, Kotha, Sravya, Haworth, Jeffrey R., Shah, Nishit J., Rao, Vidhya, Nagre, Shashikant, Ronca, Shannon E., Green, Freedom M., Aminetzah, Ari, Sollie, Frans, Kruijff, Schelto, Brom, Maarten, van Dam, Gooitzen M., Zion, Todd C.
Publicado 2023

Performance Evaluation of RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test for the Rapid Detection of SARS-CoV-2 Antibodies

por Kim, Ha Nui, Yoon, Jung, Jang, Woong Sik, Lim, Chae Seung
Publicado 2023

Can the RBD mutation R346X provide an additional fitness to the “variant soup,” including offspring of BQ and XBB of SARS-CoV-2 Omicron for the antibody resistance?

por Chatterjee, Srijan, Bhattacharya, Manojit, Dhama, Kuldeep, Lee, Sang-Soo, Chakraborty, Chiranjib
Publicado 2023

Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1

por Gonzalez-Hernandez, Mariana, Kaiser, Franziska Karola, Steffen, Imke, Ciurkiewicz, Malgorzata, van Amerongen, Geert, Tchelet, Ronen, Emalfarb, Mark, Saloheimo, Markku, Wiebe, Marilyn G., Vitikainen, Marika, Albulescu, Irina C., Bosch, Berend-Jan, Baumgärtner, Wolfgang, Haagmans, Bart L., Osterhaus, Albert D. M. E.
Publicado 2023

Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays

por Passariello, Margherita, Esposito, Speranza, Manna, Lorenzo, Rapuano Lembo, Rosa, Zollo, Immacolata, Sasso, Emanuele, Amato, Felice, De Lorenzo, Claudia
Publicado 2023

Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice

por Lee, Katherine S, Rader, Nathaniel A, Miller, Olivia A, Cooper, Melissa, Wong, Ting Y, Shahrier Amin, Md., Barbier, Mariette, Bevere, Justin R, Ernst, Robert K, Heath Damron, F.
Publicado 2023

Autoinflammatory Diseases and COVID-19 Vaccination: Analysis of SARS-CoV-2 Anti-S-RBD IgG Levels in a Cohort of Patients Receiving IL-1 Inhibitors

por Bindoli, Sara, Baggio, Chiara, Galozzi, Paola, Vesentini, Filippo, Doria, Andrea, Cosma, Chiara, Padoan, Andrea, Sfriso, Paolo
Publicado 2023

Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement

por Chen, Wen-Hsiang, Tao, Xinrong, Agrawal, Anurodh, Algaissi, Abdullah, Peng, Bi-Hung, Pollet, Jeroen, Strych, Ulrich, Bottazzi, Maria Elena, Hotez, Peter J., Lustigman, Sara, Du, Lanying, Jiang, Shibo, Tseng, Chien-Te K.
Publicado 2020

Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19

por Chen, Wen-Hsiang, Hotez, Peter J., Bottazzi, Maria Elena
Publicado 2020

Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement

por Chen, Wen-Hsiang, Tao, Xinrong, Agrawal, Anurodh Shankar, Algaissi, Abdullah, Peng, Bi-Hung, Pollet, Jeroen, Strych, Ulrich, Bottazzi, Maria Elena, Hotez, Peter J., Lustigman, Sara, Du, Lanying, Jiang, Shibo, Tseng, Chien-Te K.
Publicado 2020